Watt Christopher 4
4 · TETRAPHASE PHARMACEUTICALS INC · Filed Apr 4, 2018
Insider Transaction Report
Form 4
Watt Christopher
VP, Finance
Transactions
- Award
Restricted Stock Units
2018-04-02+30,000→ 30,000 total→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock of Tetraphase Pharmaceuticals, Inc. for no consideration.
- [F2]The restricted stock units vest on April 2, 2019.